Craniectomy implies plastic reconstruction of the skull. Cranioplasty restores and preserves cranial function, reshapes the neuro-and viscerocranium and prevents complications. [11] With emerging evidence for the benefit of early decompressive craniectomy for ischemic stroke, [25] diffuse traumatic brain injury [24] and skull-infiltrating tumors, [20] the need for cranioplasty has dramatically increased.
Good biocompatibility, appropriate defect closure with accurate fitting of the plastic reconstruction to the osseous rims, and particularly a satisfying cosmetic result are important goals. [11, 22] Furthermore, in patients with skull-penetrating tumors like meningeomas or metastases, subsequent radiographic assessment must be warranted. [1, 3, 7] Various materials have been evaluated and computerized virtually designed implants have found increasingly wider use. Among these materials are autologous bone, polymethyl methacrylate (PMMA), ceramics, hydroxyapatite, polyether ether ketone (PEEK), carbon-fiber-reinforced polymer (CFRP), and titanium. [2, 21] Titanium is a nonferrous metal of low atomic number, generating no relevant artifacts in computed tomography (CT) and magnetic resonance imaging (MRI). [8] Titanium for cranioplasty has been evaluated in previous study and some authors recommended this material as the method of choice for secondary cranioplasty. [4, 6, 12] In this retrospective series, we analyzed the feasibility of the new preformed titanium CRANIOTOP ® cranioplasty (CL Instruments, Germany) that we have utilized for the past 2 years. To our knowledge, this is the first report evaluating this novel cranioplasty.
MATERIALS AND METHODS
We had no conflict of interest. The study was approved by our local ethics committee.
Between November 2010 and December 2012, 50 consecutive patients (22 female, 28 male; mean age 50 years) received a CRANIOTOP cranioplasty in our neurosurgical department. We reviewed the charts for demographical data, time between initial surgery and secondary cranioplasty, indication for cranioplasty, pre-and postoperative radiographic data, surgical approach, peri-and postoperative complications, operative time, postoperative morbidity, and cosmetic outcome. Mean follow-up was 8 weeks and no patient was lost to follow-up.
Postoperative imaging (CT scan n = 48, MRI n = 5) within 24 hours after surgery was screened for fitting accuracy, restoration of skull contour, artifacts, and for any relevant hemorrhages.
Fabrication and operative technique
For each patient a thin sliced CT-scan was obtained, utilizing a standardized imaging protocol (helical CT, length of acquisition 1 mm, Gantry tilt 0°). The DICOM data was then transmitted to the manufacturer (CL Instruments, Germany). A 1:1 scale model of the skull, including the craniectomy [ Figure 1 ], was customized after 3-dimensional data reconstruction [ Figure 2a and b] and rapid prototyping with a 3D-plotter (Z-Cooperation, MA, USA). The implant solely consisted of titanium with minimal thickness of 0.5 mm [ Figure 3 ]. The delay between image acquisition and shipment of the cranioplasty was approximately 14 days.
After skin incision and dissection of the scalp, full exposure of the defect without dissection of the dura was performed. If necessary, lumbar cerebrospinal fluid (CSF) drainage was implanted preoperatively. Central and peripheral dural tenting sutures were applied and fixed with the plastic [ Figure 3 ]. When accurate fitting was achieved, mini skull screws (length 4 mm, Ø 1.5 mm; minimum 4, maximum 10) were applied that penetrated the external table. At the end of surgery, a soft suction drain was placed. CT-and MRI-scans were performed within 24 hours following surgery. 
RESULTS
The most common indication for craniectomy were diffuse edema due to traumatic brain injury (n = 17, 34%) and ischemic stroke of the middle cerebral artery territory (n = 12, 24%). Other reasons for craniectomy were acute subdural hematoma (n = 8, 16%), skull-infiltrating tumors (n = 6, 12%), osteomyelitis after craniotomy (n = 5, 10%), epidural hematoma (n = 1, 2%), and intracerebral hematoma (n = 1, 2%).
The mean time interval between initial craniectomy and cranioplasty was 186 days (range 17-390 days), the mean time of surgery was 124 minutes (range 78-237 minutes).
During the follow-up, all patients were satisfied with the cosmetic result. No revision for cosmetic reasons was required.
In the postoperative CT scan (n = 46) accurate fitting, restoring the skull contour, was confirmed in all patients [ Figure 4 ]. We encountered no relevant postoperative hemorrhage.
Postoperative MRI was obtained in four patients with skull-and dura-infiltrating tumors. In these four cases, the postoperative MRI was free of any artifacts, allowing assessment of residual tumor or tumor progression during the long-term follow-up [ Figures 5a and b] .
Two patients developed a subdural empyema postoperatively, in two patients an early wound dehiscence with exposure of the titanium plate occurred, and one patient had a new postoperative CSF fistula. In these five patients, explantation of the cranioplasty was necessary. Thus, the perioperative morbidity was 10%. We registered no neurological deterioration, no new seizures or neuropathies (chronic pain after wound healing), postoperatively. The implanted material was well tolerated in all cases.
The clinical characteristics and postoperative findings are presented in Table 1 .
DISCUSSION
Cranioplasty is a fundamental neurosurgical procedure that was first described in the 16 th century. [19] During the past century, various materials and techniques have appeared; the choice of material is frequently influenced by its cost as well as the surgeon's experience and preferences.
Particularly in children, the reimplantation of the autologous bone flap should be performed whenever possible to avoid any growth-related dislocation. However, in adults, presently available data does not demonstrate superiority of autologous bone. Some authors even consider the patient's own bone flap to be inferior as it is prone to osteolysis and infection. [17, 18] A very common and cheap material is PMMA, but often the cosmetic outcome is poor, especially when the cranioplasty involves parts of the forehead and of the viscerocranium. [5, 10, 16] Moreover, the minimal size of the bone flap for decompressive craniectomy should be 12 × 12 cm. [24, 25] A defect of that size becomes time-consuming and difficult to reconstruct in free-handed fashion with PMMA. Therefore, the utilization of pre-formed cranioplasties may be preferred. Materials available for computerized remodeling are ceramics, hydroxyapatite, PEEK, CFRP, and titanium. [2, 4, 9, 13, 22] The osteo-inductive potency of hydroxyapatite makes this material interesting for the clinical use in cranial reconstruction. However, the high infection rate of up to 22.4%, [18] especially when covering large defects, made some authors reject this material. Ceramic materials often have too much volume and are difficult to attach to the adjacent bone. They also typically require more extensive dissection. [23] For custom-made titanium cranioplasties, a small volume of implant material is needed. [6, 15] The plate is simply laid over the defect and fixed with mini-screws. Thus, it is not necessary to dissect the dura and the osseous rims.
The titanium cranioplasty CRANIOTOP ® was evaluated in a previous mini-series (n = 2). [20] In these two cases, the cranioplasty was applied in patients with skull-infiltrating meningeomas. The cosmetic results were satisfying and the assessment of the postoperative CT and MRI was uncomplicated. In the present study, 50 patients are presented, 4 patients received postoperative MRI and 46 patients had a postoperative CT. Both imaging modalities were free of artifacts and allowed assessment of adjacent bone, meninges and brain parenchyma.
The cosmetic result was good in all patients and replacement of the cranioplasty for cosmetic reasons was not necessary. However, in five patients the cranioplasty had to be explanted, thus the procedure-related overall morbidity in our cohort is 10% (n = 5) with an infection rate of 4% (n = 2). Severe headache, seizures or allergic reactions were not registered. Both overall morbidity and infection rate are within the range reported in a recent review of literature by Cabraja et al., the infection rate for titanium cranioplasty ranged between 0% and 4.5%. [6] In a very recent review of 127 custom-made titanium cranioplasties in 113 patients, the group of Wiggins found an infection rate of 16%. [26] Generally, the overall morbidity for cranioplasty is 0-34%. [6, 14] Further, the cost of the CRANIOTOP ® cranioplasty (3000-4500€, depending on the size) is reasonable. Osteo-inductive materials as hydroxyapatite are approximately 2.5-times more expensive.
The present analysis was designed as a feasibility study, confirming the clinical use and manageability of the CRANIOTOP ® cranioplasty. Whether this type of cranioplasty provides superior qualities than other cranioplasties must be evaluated prospectively.
LIMITATIONS
This series carries the limitations of a retrospective review. Follow-up was also limited. However, our patient population is predominantly regional and would have likely presented with important events beyond the reported follow-up.
Moreover, the cosmetic result was evaluated by subjective patient assessment and radiographic evaluation of accuracy; additional evaluation with standardized, objective tools could provide more robust data.
Despite some methodological weaknesses of our study, the custom-made titanium cranioplasty CRANIOTOP ® is safe and feasible. 
